论文部分内容阅读
目的:探讨血清C-反应蛋白(CRP)及降钙素原(PCT)在支气管哮喘合并呼吸道感染鉴别诊断中的临床价值。方法:选取2014年7月-2015年9月收治的支气管哮喘合并呼吸道感染患者48例,其中26例支气管哮喘合并细菌感染患者为A组,22例支气管哮喘合并病毒感染患者为B组,对血清CRP、PCT水平予以检测。结果:A组患者血清CRP、PCT水平同B组比较,明显较高,差异有统计学意义(P<0.05)。结论:支气管哮喘合并细菌感染患者血清CRP及PCT水平明显高于支气管哮喘合并病毒感染患者,对两种指标进行检测,利于早期正确鉴别支气管哮喘合并呼吸道感染患者,为临床治疗提供有效参考。
Objective: To investigate the clinical value of serum C-reactive protein (CRP) and procalcitonin (PCT) in the differential diagnosis of bronchial asthma with respiratory tract infection. Methods: Forty-eight patients with bronchial asthma with respiratory tract infection were selected from July 2014 to September 2015. Among them, 26 patients with bronchial asthma with bacterial infection were Group A, 22 patients with bronchial asthma with viral infection were Group B, CRP, PCT level to be tested. Results: The serum levels of CRP and PCT in group A were significantly higher than those in group B (P <0.05). Conclusion: Serum levels of CRP and PCT in patients with bronchial asthma complicated with bacterial infection are significantly higher than those in patients with bronchial asthma and viral infection. The detection of the two indicators will help early identification of patients with bronchial asthma and respiratory tract infection in the early stage and provide an effective reference for clinical treatment.